Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies

Molecular modeling and description of a newly characterized activating mutation of the EGFR gene in non-small cell lung cancer

(2012) Claudia Otto et al.   Diagnostic Pathology

Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine

(2012) Pierre-Jean Lamy et al.   Diagnostic Pathology

Molecular pathology of lung cancer: key to personalized medicine

(2012) Liang Cheng et al.   MODERN PATHOLOGY

Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma

(2011) P. Hofman et al.   ANNALS OF ONCOLOGY

EGFR Mutations and Lung Cancer

(2011) Gilda da Cunha Santos et al.   Annual Review of Pathology-Mechanisms of Disease

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

(2011) Sara Simonetti et al.   Journal of Translational Medicine

Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction

(2011) Shang-Gin Wu et al.   PLoS One

Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer

(2010) A. Kitamura et al.   CLINICAL CANCER RESEARCH

Molecular Diagnosis of Activating EGFR Mutations in Non-Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis

(2010) A. Kawahara et al.   CLINICAL CANCER RESEARCH

Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

(2010) Marie Brevet et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

(2010) Robert Pirker et al.   Journal of Thoracic Oncology

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

(2010) Yasufumi Kato et al.   Journal of Thoracic Oncology

The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma

(2010) Yoshiki Kozu et al.   LUNG CANCER

Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer

(2009) J. Yu et al.   CLINICAL CANCER RESEARCH

Evaluation of 7q31 region improves the accuracy of EGFR FISH assay in non small cell lung cancer

(2009) Laura Casorzo et al.   Diagnostic Pathology

Frequency of and variables associated with the EGFR mutation and its subtypes

(2009) Tomoaki Tanaka et al.   INTERNATIONAL JOURNAL OF CANCER

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE